Evidence and coverage policies are current to July 31, 2026 and can change.
Differential Effects of Glucagon-Like Peptide-1 Receptor Agonists on Heart Rate
Last Reviewed: Q4 2025 Originally developed to treat Type 2 Diabetes, GLP-1s have since gained FDA approval for a variety of diseases, with new indications continually emerging
Each class of drug uses a different strategy to lower blood glucose
CJC-1295 Structure CAS #: 446036-97-1 Molecular Formula: CHNO Molecular Weight: 3367.9 g/mol PubChem ID: 91976842 Ipamorelin Structure CAS #: 170851-70-4 Molecular Formula: CHNO Molecular Weight: 3367.9 g/mol PubChem ID: 91976842 CJC-1295 and Ipamorelin have been examined in endocrine, metabolic, regenerative, and systemic models, with research exploring their influence on growth hormone pathways, body composition, tissue recovery, and cellular viability